Self Help for Fatigue in Multiple Sclerosis

NCT ID: NCT01532037

Last Updated: 2021-06-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

73 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-06-30

Study Completion Date

2014-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if cognitive behavioural therapy (CBT) based self help is effective for the management of symptoms of fatigue in Multiple Sclerosis (MS).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: Fatigue is a common disabling symptom in patients with Multiple Sclerosis (MS). Cognitive behavioural therapy (CBT) has been shown to be effective in the reduction of fatigue in MS and CBT-based self-help has been shown to be effective as a low intensity intervention for anxiety and depression.

Objectives: To evaluate the effectiveness of a CBT based self-help workbook at reducing perceived impact of fatigue in a clinical sample of MS patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis Fatigue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Guided Self Help

Participant receives usual care and 4, 45 minute sessions with a therapist to support them to complete the cognitive behavioural therapy based workbook for fatigue in Multiple Sclerosis.

Group Type EXPERIMENTAL

Cognitive behavioural therapy based self help

Intervention Type OTHER

Comparison of cognitive behavioural therapy based pure self help and guided self help (support of a therapist) compared to treatment as usual

Pure Self Help

Participant receives usual care and cognitive behavioural therapy based self help work book for fatigue in multiple sclerosis to complete alone

Group Type EXPERIMENTAL

Cognitive behavioural therapy based self help

Intervention Type OTHER

Comparison of cognitive behavioural therapy based pure self help and guided self help (support of a therapist) compared to treatment as usual

Treatment as Usual

Participants receive usual care from healthcare professionals

Group Type PLACEBO_COMPARATOR

Treatment as usual

Intervention Type OTHER

Usual care from healthcare professionals with regard to patients symptoms of fatigue

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive behavioural therapy based self help

Comparison of cognitive behavioural therapy based pure self help and guided self help (support of a therapist) compared to treatment as usual

Intervention Type OTHER

Treatment as usual

Usual care from healthcare professionals with regard to patients symptoms of fatigue

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All participants will be aged 18 or over
* Will have a recognised diagnosis of relapsing remitting or primary progressive relapsing remitting Multiple Sclerosis from a neurologist
* Cognitively able to give informed consent as deemed by referring clinician in the Fife Rehabilitation Service
* Willing to consent to randomised control trial
* Fatigue as a primary symptom

Exclusion Criteria

* Patients with severe anxiety or depression (assessed by cut off on HADS)
* Patients with psychosis or personality disorders (assessed by referring clinician)
* Patients currently receiving input from psychological services for fatigue management
* Patients with suicidal ideation or plans (assessed by referring clinician)
* Patients who are unable to read the workbook or standardised questionnaires due to literacy levels or cognitive abilities will be excluded from the analysis, although if patients have literacy or cognitive problems, referral to a more suitable 1-to-1 type of therapy will be made.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Edinburgh

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kirsty Nesbitt

Role: PRINCIPAL_INVESTIGATOR

National Health Service, University of Edinburgh

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fife Rehabilitation Service

Leven, Scotland, United Kingdom

Site Status

NHS Fife

Leven, Scotland, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Chapter 4 in https://era.ed.ac.uk/bitstream/handle/1842/21011/Gallen2015.pdf

Reference Type RESULT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RCT-MS-NHS-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MS Symptom Management Study
NCT02474940 COMPLETED NA
Study of Empathy in MS
NCT05332951 COMPLETED